NupulseCV Inc is a closely held cardiovascular medical device company structured around design of devices to treat patients having advanced, chronic heart failure. The company's system is a minimally invasive, ambulatory counterpulsation device, providing certain types of patients an alternative to chronic inotropes or LVAD and particularly enabling healthcare professionals to treat pediatric patients having cardiac dysfunction. The firm's intravascular ventricular assist system (iVAS) functions as a minimally invasive heart pump. With the focus of iVAS therapy being to support a heart that is weakened by advanced heart failure -- to improve blood flow, carrying nutrients and oxygen throughout the body, thefirm's system is designed to allow patients to be discharged from hospital and to resume their daily activities.
